Objective: With the move toward competency-based education, providing genuine clinical experiences that allow trainees to learn in a safe and secure environment and assessing these experiences continue to daunt medical educators. Recently, the opportunity to develop an outpatient, ambulatory care clinic (Medical Education Teaching Clinic [METC]) to offer genuine experiences to a variety of trainees arose. To ensure that the experiences maximized quality and value to the trainees while allowing opportunities for assessment in a variety of formats, we created an engineered educational experience (E3).
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Objective: Head and neck cancer can involve the surrounding vasculature and require technically challenging vascular interventions. Our aim was to examine patients with vascular interventions and head and neck cancer to determine outcomes and best practice.
Methods: We performed a retrospective review of cancer patients treated by head and neck surgery and vascular surgery services between 2007 and 2014. Data from electronic medical records, perioperative outcomes, and survival were collected. Patency and survival were determined by Kaplan-Meier analysis.
Results: A total of 57 patients with head and neck cancer requiring vascular interventions were identified; 44 patients had squamous cell carcinoma (77%). The majority of interventions (n ¼ 36 [63%]) were performed for recurrent or persistent malignant disease, and 77% had prior radiation therapy. Tumor resection and vascular intervention were performed concurrently in 26 patients (46%). The most common indication for vascular intervention was bleeding (n ¼ 21 [37%]), including 14 vessel ruptures. Remaining indications included invasion/encasement (n ¼ 25), stenosis/occlusion (n ¼ 12), and aneurysm (n ¼ 1). The most common intervention was stenting (n ¼ 22 [41%]), followed by resection (n ¼ 20 [35%]), exposure/dissection (n ¼ 12), bypass (n ¼ 8), and embolization (n ¼ 3). Of the 22 patients who were stented, 10 (45%) had stents placed emergently (6 blowout and 4 tumor bleeding). Six patients (11%) required reintervention. The 30-day mortality was 9% (n ¼ 5), and stroke rate was 7% (n ¼ 4). Primary patency at 1 year was 66% for stents and 71% for bypass (P ¼ .604). There was a trend toward worse 1-year survival in emergency bleeding patients at 38% compared with 77% for other indications (P ¼ .109). The overall cohort survival at 1 year and 2 years was 62% and 44%, respectively.
Conclusions: Vascular involvement in head and neck cancer is a marker for poor survival. Vascular interventions are needed and feasible but should be approached with reasonable expectations and multidisciplinary collaboration. Objective: The objective of this study was to assess hemoglobin thresholds to prevent short-term mortality, adverse cardiac events, and immediate postoperative complications.
Methods: Data were extracted from the Vascular Quality Initiative database from January 2010 to December 2017. After testing for differences in key baseline demographics, logistic regression analyses were running with hemoglobin and necessary covariates predicting outcomes. Predictive probabilities were saved from these models to create receiver operating characteristic curves. When appropriate, cutoffs were created for the receiver operating characteristic curves using Youden index.
Results: There were a total of 1682 patients, 1274 (76%) male and 408 (24%) female. There were 249 carotid endarterectomies, 498 endovascular aneurysm repairs, 308 infrainguinal repairs, 213 open abdominal aortic aneurysm repairs, 233 suprainguinal repairs, and 181 thoracic endovascular aortic repairs; 38% (n ¼ 639) of the study population was anemic (hemoglobin level of <135 g/L in men, 120 g/L in women). The average preoperative hemoglobin level was 133 g/L. Preoperative hemoglobin level was associated with in-hospital mortality (women: P < .0001; men: P < .0001), adverse cardiac events (men: P < .0001; women: P < .02), and postoperative complications (men: P < .001; women: P ¼ .008). Chronic obstructive pulmonary disease (COPD) played an important role in predicting in-hospital mortality (women: P ¼ .008; men: P ¼ .01), with a higher expected mortality in those with COPD. Predicted hemoglobin cutoff levels were 130 g/L with COPD and 116 g/L without COPD in women and 127 g/L with COPD and 148 g/L without COPD in men.
Conclusions: Preoperative anemia is a powerful predictor of immediate mortality, adverse cardiac events, and postoperative complications. There are important sex differences in risk of adverse events, and preoperative anemia should be aggressively treated in vascular surgery. Objective: Canada is currently facing an opioid crisis. In 2016, there were 1.3 million Canadians who commenced opioid treatment, and nearly 3000 Canadians suffered an opioid-related death. Our aim was to assess the rate and associated risk factors of prolonged opioid use in postoperative vascular surgery patients with the goal of informing and improving patient care.
Methods: In this population-based retrospective cohort study, patients' data were collected for eligible vascular surgery patients $65 years of age who underwent one of five surgical interventions at the Toronto General Hospital during November 22, 2016 , to March 31, 2017 . Data were obtained from electronic patient records, the Vascular Quality Initiative, and the Ontario Drug Benefit databases. Prolonged opioid use was defined as ongoing opioid dispensing for >90 days after discharge.
